|
Proteintech
anti dusp16 Anti Dusp16, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/mkp/DUSP16+Antibody/pmc12145754-92-34-35 Average 93 stars, based on 1 article reviews
anti dusp16 - by Bioz Stars,
2026-11
93/100 stars
|
Buy from Supplier |
|
Santa Cruz Biotechnology
mkp 2 Mkp 2, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/mkp/MKP-2+Antibody/pm18938228-83-51-52 Average 93 stars, based on 1 article reviews
mkp 2 - by Bioz Stars,
2026-11
93/100 stars
|
Buy from Supplier |
|
Santa Cruz Biotechnology
dusp6 sirna ![]() Dusp6 Sirna, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/mkp/MKP-3+siRNA/pmc04747493-48-18-32 Average 93 stars, based on 1 article reviews
dusp6 sirna - by Bioz Stars,
2026-11
93/100 stars
|
Buy from Supplier |
|
Santa Cruz Biotechnology
mkp ![]() Mkp, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/mkp/MKP-3+Antibody/10__1165_slash_rcmb__2007___0356oc-96-5-17 Average 93 stars, based on 1 article reviews
mkp - by Bioz Stars,
2026-11
93/100 stars
|
Buy from Supplier |
|
Santa Cruz Biotechnology
mkp 1 ![]() Mkp 1, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/mkp/MKP-1+Antibody/10__4238_slash_2015__may__4__7-22-2-9 Average 94 stars, based on 1 article reviews
mkp 1 - by Bioz Stars,
2026-11
94/100 stars
|
Buy from Supplier |
|
Santa Cruz Biotechnology
mkp 1 sirna ![]() Mkp 1 Sirna, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/mkp/MKP-1+siRNA/pmc04657575-45-0-8 Average 93 stars, based on 1 article reviews
mkp 1 sirna - by Bioz Stars,
2026-11
93/100 stars
|
Buy from Supplier |
|
Proteintech
dusp7 mkpx 26910 1 ap ![]() Dusp7 Mkpx 26910 1 Ap, supplied by Proteintech, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/mkp/DUSP7%2FPYST2+Antibody/pm29041978-56-35-40 Average 91 stars, based on 1 article reviews
dusp7 mkpx 26910 1 ap - by Bioz Stars,
2026-11
91/100 stars
|
Buy from Supplier |
|
Santa Cruz Biotechnology
dusp10 sirna ![]() Dusp10 Sirna, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/mkp/MKP-5+siRNA/pmc06321923-179-4-7 Average 90 stars, based on 1 article reviews
dusp10 sirna - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
MedChemExpress
dusp1 ![]() Dusp1, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/mkp/DUSP1+Antibody/pmc12830252-55-51-52 Average 94 stars, based on 1 article reviews
dusp1 - by Bioz Stars,
2026-11
94/100 stars
|
Buy from Supplier |
|
Santa Cruz Biotechnology
mkp5 ![]() Mkp5, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/mkp/MKP-5+Antibody/pmc10987508-12-0-2 Average 92 stars, based on 1 article reviews
mkp5 - by Bioz Stars,
2026-11
92/100 stars
|
Buy from Supplier |
|
ABclonal Biotechnology
usp10 ![]() Usp10, supplied by ABclonal Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/mkp/DUSP10+Rabbit+pAb/pmc12031808-54-3-4 Average 93 stars, based on 1 article reviews
usp10 - by Bioz Stars,
2026-11
93/100 stars
|
Buy from Supplier |
|
Proteintech
anti dusp10 ![]() Anti Dusp10, supplied by Proteintech, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/mkp/DUSP10+Antibody/pm38565204-44-53-58 Average 92 stars, based on 1 article reviews
anti dusp10 - by Bioz Stars,
2026-11
92/100 stars
|
Buy from Supplier |
Image Search Results
Journal: PLoS ONE
Article Title: Differential Roles for DUSP Family Members in Epithelial-to-Mesenchymal Transition and Cancer Stem Cell Regulation in Breast Cancer
doi: 10.1371/journal.pone.0148065
Figure Lengend Snippet: DUSP1 , DUSP4 , and DUSP6 transcript levels measured by real-time PCR in ( A ) MCF-7 and MDA-MB-231 cells. Data are expressed as arbitrary copy numbers normalised to PPIA and are representative of the mean ± SE. ( B ) MCF-7 cells after incubation with PMA for various periods of time. Spline curves represent mean arbitrary copy numbers normalised to PPIA of two independent experiments. ( C ) MCF-7 cells after incubation with vehicle alone or in the presence of either PMA or PMA+TGF-β for 60 h. Data are expressed as relative fold change to MCF-7 normalised to PPIA and are representative of the mean ± SE of four independent experiments. MCF-7 cells were incubated with vehicle alone or in the presence of PMA for 60 h. Transcript levels measured by real-time PCR of: ( D ) CDH1 , VIM , FN1 , SNAI1 , SNAI2 , CD44 , and PLAUR and ( E ) DUSP1 , DUSP4 , and DUSP6 . Data are presented as relative fold change to MCF-7 normalised to PPIA and are representative of the mean ± SE. ( F ) DUSP1 , DUSP4 , and DUSP6 transcript levels in PKC-θ siRNA transfected cells. Data are expressed as relative fold change to MCF-7 MOCK siRNA normalised to PPIA and are representative of the mean ± SE for four experiments. ( G ) PKC-θ ChIP-seq across DUSP1 , DUSP4 , and DUSP6 transcripts in MCF-7 and MCF-7/PMA cells. Data are shown in the UCSC Genome Browser. The scale in all UCSC images is indicated on the y-axis as numbers in reads per million mapped reads.
Article Snippet: Forward transfection reactions were performed for 6 h with 50 nM human DUSP1 siRNA (sc-35937), DUSP4 siRNA (sc-38998),
Techniques: Real-time Polymerase Chain Reaction, Incubation, Transfection, ChIP-sequencing
Journal: PLoS ONE
Article Title: Differential Roles for DUSP Family Members in Epithelial-to-Mesenchymal Transition and Cancer Stem Cell Regulation in Breast Cancer
doi: 10.1371/journal.pone.0148065
Figure Lengend Snippet: Confocal laser scanning microscopy was performed on either MDA-MB-231 cells or MCF-7 cells treated with vehicle alone or PMA for 60 h. Cells were fixed and probed with primary rabbit, mouse, or goat antibodies to DUSP1, DUSP4, and DUSP6, respectively, followed by the corresponding secondary antibody conjugated to Alexa-Fluor 568 or Alexa-Fluor 488. Fn/c values for: ( A ) MCF-7 and MCF-7/PMA cells; ( B ) MDA-MB-231 cells. Data shown represent the mean ± SE. Value 1 = equal cytoplasmic and nuclear fractions; >1 = nuclear bias; <1 = cytoplasmic bias. MCF-7 cells were probed with either: ( C ) primary anti-rabbit-DUSP1 and anti-mouse-H3K9me1; or ( D ) primary anti-mouse-DUSP4 and anti-rabbit-H3K27ac or anti-rabbit-H3K4me1. All antibodies were conjugated to Alexa-Fluor 568 or Alexa-Fluor 488. MDA-MB-231 cells probed with either: ( E ) primary anti-rabbit-DUSP1 and anti-mouse-H3K4me3 or anti-mouse-H3K9me1 or ( F ) primary anti-mouse-DUSP4 and anti-rabbit-H3K4me1 or anti-rabbit-H3K27ac. All antibodies were conjugated to Alexa-Fluor 568 or Alexa-Fluor 488. Representative images for each dataset are shown: green = DUSPs; red = histone marks; yellow = overlap between DUSPs and histone mark fluorescence signals. The plot-profile feature of ImageJ was used to plot the fluorescence signal intensity along a single line spanning the nucleus (n = 5 lines per nucleus, 5 individual cells). The average fluorescence signal intensity for the indicated pair of antibodies was plotted for each point on the line ±SE. Signal was plotted to compare how the signals for each antibody varied compared to the opposite antibody. The PCC was determined for each plot profile. PCC indicates the strength of relation between the two fluorochrome signals for at least 20 individual cells ± SE. Colours from representative images correspond to plot profiles.
Article Snippet: Forward transfection reactions were performed for 6 h with 50 nM human DUSP1 siRNA (sc-35937), DUSP4 siRNA (sc-38998),
Techniques: Confocal Laser Scanning Microscopy, Fluorescence
Journal: PLoS ONE
Article Title: Differential Roles for DUSP Family Members in Epithelial-to-Mesenchymal Transition and Cancer Stem Cell Regulation in Breast Cancer
doi: 10.1371/journal.pone.0148065
Figure Lengend Snippet: MCF-7 cells were transfected with MOCK, DUSP1, DUSP4, or DUSP6 siRNAs and subsequently incubated with either vehicle or in the presence of PMA for 60 h. ( A ) Percentage of CD44 hi /CD24 lo /EpCAM + CSC-like cells as measured by flow cytometry after transfection ± SE. Numbers above each column represent percentage inhibition (-) or promotion (+) relative to MOCK siRNA for three independent experiments. MCF-7 and MDA-MB-231 were inhibited with either NSC 95397 or triptolide for 24 h. ( B ) MCF-7 cells were then incubated with either vehicle alone or PMA for 60 h. Bar graph indicates percentage inhibition of CD44 hi /CD24 lo /EpCAM + CSC-like MCF-7, MCF-7/PMA AD , and MCF-7/PMA SUS cells after inhibition ± SE for two independent experiments. ( C ) Bar graph indicates CD44 hi /CD24 lo /EpCAM + CSC-like MDA-MB-231 cells after inhibition ± SE for two independent experiments. ( D ) mRNA levels CDH1 , VIM , and FN1 in MDA-MB-231 cells after inhibition. Data represent the mean relative fold change to untreated cells normalised to PPIA ± SE for two independent experiments.
Article Snippet: Forward transfection reactions were performed for 6 h with 50 nM human DUSP1 siRNA (sc-35937), DUSP4 siRNA (sc-38998),
Techniques: Transfection, Incubation, Flow Cytometry, Inhibition
Journal: PLoS ONE
Article Title: Differential Roles for DUSP Family Members in Epithelial-to-Mesenchymal Transition and Cancer Stem Cell Regulation in Breast Cancer
doi: 10.1371/journal.pone.0148065
Figure Lengend Snippet: DUSP6 expression in a breast cancer cell line and breast cancer tissues were examined by immunohistochemistry. ( A ) Table summarising DUSP6 expression in the indicated breast tissues. ( B ) Cell block of MDA-MB-231 cells (x630). ( C ) Grade 2 ER + /PR + /HER2 - breast cancer (x400). ( D ) Grade 3 triple-negative (ER - /PR - /HER2 - ) breast cancer (x400). ( E ) Grade 3 ER + /PR + /HER2 + breast cancer (x400) with benign breast duct. ( F ) Grade 3 ER - /PR - /HER2 + breast cancer (x400).
Article Snippet: Forward transfection reactions were performed for 6 h with 50 nM human DUSP1 siRNA (sc-35937), DUSP4 siRNA (sc-38998),
Techniques: Expressing, Immunohistochemistry, Blocking Assay
Journal: Journal of Virology
Article Title: DUSP10 Negatively Regulates the Inflammatory Response to Rhinovirus through Interleukin-1β Signaling
doi: 10.1128/JVI.01659-18
Figure Lengend Snippet: DUSP10 expression is decreased by RV infection. PBECs were infected with RV1B (MOI = 3) or RV16 (MOI = 4) or treated with IL-1β (100 ng/ml) for 24 h, and cell lysates were collected at the indicated time points. DUSP1 (A), DUSP4 (B), and DUSP10 (C) expression was measured using qRT-PCR. Data shown are means ± SEM for 3 individual donors. The significance of differences versus uninfected control cells (0 h), as measured by one-way ANOVA and Dunnett’s posttest on log Δ C T values, is indicated as follows: *, P ≤ 0.05.
Article Snippet: Lipofectamine 2000 (Invitrogen) and
Techniques: Expressing, Infection, Quantitative RT-PCR, Control
Journal: Journal of Virology
Article Title: DUSP10 Negatively Regulates the Inflammatory Response to Rhinovirus through Interleukin-1β Signaling
doi: 10.1128/JVI.01659-18
Figure Lengend Snippet: DUSP10 protein expression is decreased by RV infection. PBECs were infected with RV1B (MOI = 3) (A) or RV16 (MOI = 4) (B) or treated with IL-1β (100 ng/ml) (C) for 24 h, and cell lysates were collected at the indicated time points. DUSP10 and actin expression was measured by Western blotting. Data shown are means ± SEM for densitometry analysis of cells from 3 individual donors, with representative blots shown below the graphs. The significance of differences, as measured by one-way ANOVA and Dunnett’s posttest on log values, is indicated as follows: *, P ≤ 0.05. Note that blots shown are segments of longer time courses.
Article Snippet: Lipofectamine 2000 (Invitrogen) and
Techniques: Expressing, Infection, Western Blot
Journal: Journal of Virology
Article Title: DUSP10 Negatively Regulates the Inflammatory Response to Rhinovirus through Interleukin-1β Signaling
doi: 10.1128/JVI.01659-18
Figure Lengend Snippet: DUSP10 knockdown does not affect the response of PBECs to RV infection. PBECs were left untransfected or treated with DUSP10 (D10) or control (Ctrl) siRNA (100 nM) for 48 h. Cell lysates and supernatants were collected and analyzed for DUSP10 expression by qRT-PCR (A) and Western blotting (B). PBECs were then infected with RV1B (MOI = 3) or RV16 (MOI = 4) or treated with poly(I:C) (25 μg/ml). Cell lysates and supernatants were collected after 24 h and analyzed by ELISA for CXCL8 (C) and CCL5 (E) or after 16 h and analyzed by qRT-PCR for IFN-β (D). (F) RV RNA levels after 24 h were measured using qRT-PCR. Data shown are means ± SEM for 3 individual donors (A to E) or 4 individual donors (F). The significance of differences between siRNA treatments, as measured using one-way ANOVA and Dunnett’s posttest on log Δ C T values (A) or log protein expression values (B) or using two-way ANOVA and Sidak’s posttest on log data (C to F), is indicated as follows: *, P ≤ 0.05.
Article Snippet: Lipofectamine 2000 (Invitrogen) and
Techniques: Knockdown, Infection, Control, Expressing, Quantitative RT-PCR, Western Blot, Enzyme-linked Immunosorbent Assay
Journal: Journal of Virology
Article Title: DUSP10 Negatively Regulates the Inflammatory Response to Rhinovirus through Interleukin-1β Signaling
doi: 10.1128/JVI.01659-18
Figure Lengend Snippet: DUSP10 knockdown increases cytokine production but not MAPK activation in response to IL-1β. PBECs were treated with DUSP10 (D10) or control (Ctrl) siRNA (100 nM) for 48 h prior to stimulation with IL-1β (1 to 100 ng/ml) for 24 h. Cell lysates and supernatants were collected and CXCL8 measured by qRT-PCR (A) and ELISA (B) for 4 individual donors. (C) PBECs were treated with siRNA for 48 h prior to stimulation with IL-1β (100 ng/ml) for 30 min. Cell lysates were collected, and levels of phosphorylated p38 and JNK and total actin were measured using Western blotting. Data shown are means ± SEM of band densities for 3 individual donors, and representative blots are shown. The significance of differences between siRNA treatments, as measured by two-way ANOVA and Sidak’s posttest on log data, is indicated as follows: *, P ≤ 0.05.
Article Snippet: Lipofectamine 2000 (Invitrogen) and
Techniques: Knockdown, Activation Assay, Control, Quantitative RT-PCR, Enzyme-linked Immunosorbent Assay, Western Blot
Journal: Journal of Virology
Article Title: DUSP10 Negatively Regulates the Inflammatory Response to Rhinovirus through Interleukin-1β Signaling
doi: 10.1128/JVI.01659-18
Figure Lengend Snippet: Effect of DUSP10 knockdown on cytokine expression in response to IL-1β. PBECs were treated with DUSP10 (D10) or control (Ctrl) siRNA (100 nM) for 48 h prior to stimulation with IL-1β (10 ng/ml) for 24 h. Supernatants were collected and cytokine array analysis performed. Data presented are spot densities normalized to cell number ( n = 1).
Article Snippet: Lipofectamine 2000 (Invitrogen) and
Techniques: Knockdown, Expressing, Control
Journal: Journal of Virology
Article Title: DUSP10 Negatively Regulates the Inflammatory Response to Rhinovirus through Interleukin-1β Signaling
doi: 10.1128/JVI.01659-18
Figure Lengend Snippet: IL-1β potentiates the response of PBECs to RV infection. PBECs were treated with control (Ctrl) or DUSP10 (D10) siRNA (100 nM) for 48 h prior to stimulation with IL-1β (1 or 10 ng/ml) and/or infection with RV16 (MOI = 4) (A and B), RV1B (MOI = 3) (C), or RV14 (D) for 24 h. Cell supernatants and lysates were collected and CXCL8 measured by qRT-PCR (A) and ELISA (B to D). The significance of differences between Ctrl and D10 siRNAs, as measured by two-way ANOVA and Sidak’s posttest, is indicated as follows: *, P ≤ 0.05; **, P ≤ 0.01; ***, P ≤ 0.001; and ****, P ≤ 0.0001 ( n = 3 individual donors). The significance of differences between RV alone and RV in combination with IL-1β, as measured by two-way ANOVA and Dunnett’s posttest on log raw data, is indicated as follows: #, P ≤ 0.05; ##, P ≤ 0.01; ###, P ≤ 0.001; and ####, P ≤ 0.0001 ( n = 3 individual donors).
Article Snippet: Lipofectamine 2000 (Invitrogen) and
Techniques: Infection, Control, Quantitative RT-PCR, Enzyme-linked Immunosorbent Assay
Journal: Journal of Virology
Article Title: DUSP10 Negatively Regulates the Inflammatory Response to Rhinovirus through Interleukin-1β Signaling
doi: 10.1128/JVI.01659-18
Figure Lengend Snippet: DUSP10 expression is decreased by RV infection in COPD cells, and DUSP10 knockdown increases CXCL8 release. COPD PBECs were infected with RV1B (MOI = 3) or RV16 (MOI = 4) or treated with IL-1β (100 ng/ml) for 24 h, and cell lysates were collected at the indicated time points. DUSP10 expression was measured using qRT-PCR (A) and Western blotting (B). Data shown are means ± SEM for individual donors. Densitometry results are shown in panel B, and a representative blot is shown in panel C. The significance of differences was measured by one-way ANOVA and Dunnett’s posttest on log Δ C T values (A) or log densitometric values (B). (D) COPD PBECs were treated with control (Ctrl) or DUSP10 (D10) siRNA (100 nM) for 48 h prior to stimulation with IL-1β (1 or 10 ng/ml) and/or infection with RV16 (MOI = 4) for 24 h. Cell supernatants were collected and CXCL8 measured by ELISA ( n = 2 individual donors).
Article Snippet: Lipofectamine 2000 (Invitrogen) and
Techniques: Expressing, Infection, Knockdown, Quantitative RT-PCR, Western Blot, Control, Enzyme-linked Immunosorbent Assay
Journal: Biochemistry and Biophysics Reports
Article Title: Bifendate inhibits cell PARthanatos by activating the MEK/ERK pathway
doi: 10.1016/j.bbrep.2026.102454
Figure Lengend Snippet: DDB sustains cellular phospho-ERK levels. (A–B) HeLa cells were pre-treated with DDB for 24 h, exposed to MNNG (60 μM, 15 min) and cultured for a further 8 h. ERK1 and phospho-ERK1/2 expression were analysed by immunoblot (A) and densitometry (B). (C) Cells pre-treated with DDB for 24 h were challenged with MNNG (60 μM, 15 min) and harvested 4 h later; MEK1/2 and phospho-MEK1 levels were analysed by immunoblot. (D) The thermal stability of MEK and ERK after 24 h pretreatment with DDB (25 μM) or DMSO was detected by Western blot. (E) The grey values of each protein band were analysed quantitatively. (n = 3). The values are expressed as the means ± SDs. Statistical analysis was performed using T-test. *p < 0.05. (F) The thermal stability of DUSP1 after 24 h pretreatment with DDB (25 μM) or DMSO was detected by Western blot. (G) The grey values of protein band were analysed quantitatively. (n = 3). The values are expressed as the means ± SDs. Statistical analysis was performed using T-test. (H) Cells were pre-treated or not with DDB for 24 h, exposed to MNNG (60 μM, 15 min) and cultured for 4 h then phospho-Bad expression was analysed. (I) Mitochondrial membrane potential was assessed by JC-1 staining after the indicated treatments. Scale bar: 50 μm. The values are expressed as the means ± SDs (n = 3). Statistical analysis was performed using one-way ANOVA followed by Tukey's test. **p < 0.01.
Article Snippet: After sealing with 5 % skimmed milk, the membrane was incubated successively with the primary antibody (PAR/pADPr, R&D, #4335-MC-100; PARP1, ABclonal, #A0010; AIF, Santa Cruz Biotechnology, #sc-13116; TOMM20, Beyotime, #AF1717; MIF, Beyotime, #AF7467; β-Tubulin, Beyotime, #AF2839; ERK1, Beyotime, #AF1315; Phospho-Erk1 (Thr202/Tyr204)/Erk2 (Thr185/Tyr187), Beyotime, #AF1891); MEK1/2, Beyotime, #AF1057; Phospho-MEK1 (Ser218/222), Beyotime, #AF1786;
Techniques: Cell Culture, Expressing, Western Blot, Membrane, Staining
Journal: Scientific Reports
Article Title: 6-Gingerol attenuates hepatic ischemia/reperfusion injury through regulating MKP5-mediated P38/JNK pathway
doi: 10.1038/s41598-024-58392-1
Figure Lengend Snippet: 6-Gingerol promoted the expression of MKP5 in vivo and in vitro. ( A ) mRNA expression of MKP5 in liver tissues, ( B ) mRNA expression of MKP5 in AML12 cells, ( C ) protein detection and ( D ) statistical analysis of MKP5 in liver tissues, ( E ) protein detection and ( F ) statistical analysis of MKP5 in liver AML12 cells. ** P < 0.01 versus sham group; ## P < 0.01 versus I/R group; $$ P < 0.01 versus control group; && P < 0.01 versus H/R group.
Article Snippet:
Techniques: Expressing, In Vivo, In Vitro, Control
Journal: Scientific Reports
Article Title: 6-Gingerol attenuates hepatic ischemia/reperfusion injury through regulating MKP5-mediated P38/JNK pathway
doi: 10.1038/s41598-024-58392-1
Figure Lengend Snippet: Knockout of MKP5 attenuated the hepatoprotective effect of 6-Gingerol. ( A , B ) Serum ALT and AST level, ( C ) H&E staining and ( D ) necrotic area statistics, ( E – H ) Il-1β, Il-6, Tnf-α and Mcp1 mRNA expression, ( I ) TUNEL staining (red fluorescence indicates TUNEL positives cells) and ( J ) statistical analysis, ( K – N ) MKP5 protein and P38/JNK pathway protein detection. ** P < 0.01 versus sham group; ## P < 0.01 versus I/R group; $$ P < 0.01 versus I/R group; ## P < 0.01 versus I/R +100 mg/kg group.
Article Snippet:
Techniques: Knock-Out, Staining, Expressing, TUNEL Assay, Fluorescence
Journal: Cell Biology and Toxicology
Article Title: Ubiquitin-specific peptidase 10 attenuates bleomycin-induced pulmonary fibrosis via modulating autophagy depending on sirtuin 6-mediated AKT/mTOR
doi: 10.1007/s10565-025-10031-9
Figure Lengend Snippet: USP10 expression is decreased in the lungs from BLM-induced mice. (A) Schematic chart showing the induction of BLM-induced IPF and experiment protocol. (B) USP10 expression values in GSE37635 datasets ( https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE37635 ) based on the GEO database ( https://www.ncbi.nlm.nih.gov/geo/geo2r/ ) showed that USP10 expression was downregulated in BLM-induced mice lung tissues at the indicated times. Each bar represents the mean ± SD; * p < 0.05 vs. CTL group. (C) Western blot and Real-time PCR of USP10 in lungs from BLM-treated mice showed that USP10 expression was downregulated in lung tissues at the indicated times. Each bar represents the mean ± SD; * p < 0.05 vs. CTL group. (D) Representative images of double-labeled immunofluorescence staining of USP10 (red) and Vimentin (green) in pulmonary tissues. Blue indicates nucleus marked with DAPI. USP10, ubiquitin-specific peptidase 10; BLM, bleomycin; IPF, idiopathic pulmonary fibrosis; GEO, Gene Expression Omnibus; CTL, control
Article Snippet: Antibodies used including:
Techniques: Expressing, Western Blot, Real-time Polymerase Chain Reaction, Labeling, Immunofluorescence, Staining, Ubiquitin Proteomics, Gene Expression, Control
Journal: Cell Biology and Toxicology
Article Title: Ubiquitin-specific peptidase 10 attenuates bleomycin-induced pulmonary fibrosis via modulating autophagy depending on sirtuin 6-mediated AKT/mTOR
doi: 10.1007/s10565-025-10031-9
Figure Lengend Snippet: Anti-fibrotic function of USP10 in mouse lung fibroblasts. (A) Identification of mouse lung fibroblasts; the cells were observed to display fusiform. (B) Real-time PCR of USP10 showing that USP10 was decreased in MLF after treatment with TGF-β1. Each bar represents the mean ± SD; * p < 0.05 vs. CTL group. (C) Western blot of USP10 in MLF after TGF-β1 treatment. (D) Immunofluorescence staining of α-SMA in the TGF-β1-treated fibroblasts. α-SMA expression was increased after TGF-β1 treatment and decreased by USP10 overexpression. Blue indicates nucleus marked with DAPI. (E) Western blot results indicated that USP10 was downregulated by TGF-β1 treatment and reversed after overexpression of USP10. (F) Real-time PCR results exhibited that COL1 A, fibronectin, and α-SMA were highly upregulated by TGF-β1 treatment. USP10 overexpression inhibited the expression of COL1 A, fibronectin, and α-SMA. Each bar represents the mean ± SD; * p < 0.05 vs. CTL group; # p < 0.05 vs. TGF-β1 + Vector group. USP10, ubiquitin-specific peptidase 10; α-SMA, α-smooth muscle actin; COL1 A, collagen type I alpha1. MLF, mouse lung fibroblasts
Article Snippet: Antibodies used including:
Techniques: Real-time Polymerase Chain Reaction, Western Blot, Immunofluorescence, Staining, Expressing, Over Expression, Plasmid Preparation, Ubiquitin Proteomics
Journal: Cell Biology and Toxicology
Article Title: Ubiquitin-specific peptidase 10 attenuates bleomycin-induced pulmonary fibrosis via modulating autophagy depending on sirtuin 6-mediated AKT/mTOR
doi: 10.1007/s10565-025-10031-9
Figure Lengend Snippet: USP10 is downregulated in the lungs of IPF patients. (A) Western blot and Real-time PCR of USP10 in lungs from IPF patients and healthy individuals showed that USP10 expression was downregulated. Each bar represents the mean ± SD; * p < 0.05 vs. CTL group. (B) Representative images of double-labeled immunofluorescence staining of USP10 (red) and Vimentin (green) in the lung sections from patients with IPF. Blue indicates nucleus marked with DAPI. USP10, ubiquitin-specific peptidase 10; IPF, idiopathic pulmonary fibrosis; CTL, control
Article Snippet: Antibodies used including:
Techniques: Western Blot, Real-time Polymerase Chain Reaction, Expressing, Labeling, Immunofluorescence, Staining, Ubiquitin Proteomics, Control
Journal: Cell Biology and Toxicology
Article Title: Ubiquitin-specific peptidase 10 attenuates bleomycin-induced pulmonary fibrosis via modulating autophagy depending on sirtuin 6-mediated AKT/mTOR
doi: 10.1007/s10565-025-10031-9
Figure Lengend Snippet: USP10 overexpression ameliorates the symptoms of pulmonary fibrosis in BLM-induced mice. (A) Western blot results confirmed that overexpressed USP10 in the lung tissues, indicating that the lentivirus vector was constructed successfully. (B) Effect of USP10 on lung index of BLM-induced mice. * p < 0.05 vs. CTL, # p < 0.05 vs. BLM + Vector group, & p < 0.05 vs. BLM + USP10 Lv group. (C, D) H&E and Masson images indicated that the alveolar wall became thicker and excess collagen was deposited in lung tissues from BLM-treated mice. USP10 overexpression alleviated collagen deposition, and 3-MA treatment aggregated these symptoms. USP10, ubiquitin-specific peptidase 10; BLM, bleomycin; IPF, idiopathic pulmonary fibrosis; CTL, control. Lv, lentiviral vector
Article Snippet: Antibodies used including:
Techniques: Over Expression, Western Blot, Plasmid Preparation, Construct, Ubiquitin Proteomics, Control
Journal: Cell Biology and Toxicology
Article Title: Ubiquitin-specific peptidase 10 attenuates bleomycin-induced pulmonary fibrosis via modulating autophagy depending on sirtuin 6-mediated AKT/mTOR
doi: 10.1007/s10565-025-10031-9
Figure Lengend Snippet: USP10 overexpression promotes autophagy induction in BLM-induced lung tissues. (A) Immumohistochemical staining showing that α-SMA was highly expressed in BLM-treated mouse lung slices, USP10 overexpression decreased α-SMA expression. (B) Representative images of double-labeled immunofluorescence staining of USP10 (red) and Vimentin (green) in mouse lung tissues in different groups. Blue indicates nucleus marked with DAPI. (C) Fibrotic proteins including COL1 A, fibronectin, and α-SMA increased in the BLM-treated mice. USP10 overexpression reversed fibrotic protein expression. (D) BLM treatment resulted in marked upregulation of LC3II and downregulation of p62 protein levels. USP10 overexpression reversed the marker of autophagosome expression. (E) Representative images of autophagosomes examined using a TEM analysis in mouse lung slices. Scale bar = 1μm. USP10, ubiquitin-specific peptidase 10; BLM, bleomycin; α-SMA, α-smooth muscle actin; COL1 A, collagen type I alpha1; TEM, transmission electron microscope
Article Snippet: Antibodies used including:
Techniques: Over Expression, Staining, Expressing, Labeling, Immunofluorescence, Marker, Ubiquitin Proteomics, Transmission Assay, Microscopy
Journal: Cell Biology and Toxicology
Article Title: Ubiquitin-specific peptidase 10 attenuates bleomycin-induced pulmonary fibrosis via modulating autophagy depending on sirtuin 6-mediated AKT/mTOR
doi: 10.1007/s10565-025-10031-9
Figure Lengend Snippet: Effect of USP10 on Sirt6-mediated AKT/mTOR signaling pathway. (A) Representative images of double-labeled immunofluorescence staining of USP10 (red) and Sirt6 (green) in pulmonary tissues. Blue indicates nucleus marked with DAPI. (B) Western blot results exhibited that Sirt6, p-AKT, and p-mTOR were highly upregulated by BLM treatment. USP10 overexpression inhibited the expression of p-AKT and p-mTOR. USP10, ubiquitin-specific peptidase 10; Sirt6, Sirtuin 6; BLM, bleomycin
Article Snippet: Antibodies used including:
Techniques: Labeling, Immunofluorescence, Staining, Western Blot, Over Expression, Expressing, Ubiquitin Proteomics
Journal: Cell Biology and Toxicology
Article Title: Ubiquitin-specific peptidase 10 attenuates bleomycin-induced pulmonary fibrosis via modulating autophagy depending on sirtuin 6-mediated AKT/mTOR
doi: 10.1007/s10565-025-10031-9
Figure Lengend Snippet: Effect of USP10 on fibrosis and autophagy in TGF-β1-treated mouse lung fibroblasts. (A) TGF-β1 treatment resulted in the downregulation of LC3II and upregulation of p62 protein levels. USP10 overexpression reversed the marker of autophagosome expression. (B) Representative images of autophagosomes examined using a TEM analysis in MLF. Scale bar = 500 nm. (C, D) Western blot results exhibited that p-AKT and p-mTOR were highly upregulated by TGF-β1 treatment. USP10 overexpression inhibited the levels of p-AKT and p-mTOR. (E) Fibrotic proteins including COL1 A, fibronectin, and α-SMA increased in the TGF-β1-treated fibroblast following USP10 overexpression. 3-MA treatment reversed fibrotic protein expression. Each bar represents the mean ± SD; * p < 0.05 vs. TGF-β1 + Vector group; # p < 0.05 vs. TGF-β1 + USP10 Lv group. (F) Immunofluorescence staining of α-SMA in TGF-β1-treated mouse lung fibroblast following USP10 overexpression, and 3-MA treatment increased α-SMA expression. USP10, ubiquitin-specific peptidase 10; α-SMA, α-smooth muscle actin; COL1 A, collagen type I alpha1; TEM, transmission electron microscope. MLF, mouse lung fibroblasts
Article Snippet: Antibodies used including:
Techniques: Over Expression, Marker, Expressing, Western Blot, Plasmid Preparation, Immunofluorescence, Staining, Ubiquitin Proteomics, Transmission Assay, Microscopy
Journal: Cell Biology and Toxicology
Article Title: Ubiquitin-specific peptidase 10 attenuates bleomycin-induced pulmonary fibrosis via modulating autophagy depending on sirtuin 6-mediated AKT/mTOR
doi: 10.1007/s10565-025-10031-9
Figure Lengend Snippet: Effect of USP10 on fibrosis and autophagy depends on Sirt6. (A) Representative images of double-labeled immunofluorescence staining of USP10 (red) and Sirt6 (green) in MLF. Blue indicates nucleus marked with DAPI. (B) Western blot results showed that Sirt6 expression was increased by TGF-β1 treatment and was further promoted by USP10 overexpression. (C) Stability testing uncovered that Sirt6 stability was promoted by USP10 overexpression. Results of Western blot elucidated that USP10 overexpression enhanced the expression of Sirt6 (D) and LC3II/LC3I ratio (E) , and inhibited p-AKT (F) and p-mTOR (G) levels. Interference of Sirt6 caused these expression trends to be reversed. USP10, ubiquitin-specific peptidase 10; Sirt6, Sirtuin 6
Article Snippet: Antibodies used including:
Techniques: Labeling, Immunofluorescence, Staining, Western Blot, Expressing, Over Expression, Ubiquitin Proteomics